undamentalytics Newsletter
Sign in

Fuller H B Co (FUL) stock

Add to watchlist

Add holding +

NYSE: FUL NYSE Specialty Chemicals Next results ~January 13, 2027

C+ Fundamentals grade

Fuller H B Co is a US-listed company in the specialty chemicals industry. Its financial year ends in November.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: after-tax interest is 82% of the cash flow left for shareholders; our flat discount rate doesn't yet reflect debt this heavy.

Price vs value

Under review: after-tax interest is 82% of the cash flow left for shareholders; our flat discount rate doesn't yet reflect debt this heavy. We'll show the comparison once resolved.

Fuller H B Co valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders10 buying, 1 selling13 purchases and 2 sales by directors and officers, last 12 monthsInsider trades
  • Funds174 adding, 149 cuttingOf 56 active managers that changed their stake, 31 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Fuller H B files

Where Fuller H B Co stands after its latest 10-Q

Revenue for the twelve months to August 2026 was $3.55bn, up 1.5% on a year earlier, against a decline of 0.6% a quarter earlier. Free-cash-flow margin held at 2.8%. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 2 of our 6 financial-health checks.

Our model value for Fuller H B is under review, so past values are not shown until it is resolved.

Source: 10-Q filed September 24, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~January 13, 2027 (estimated)

Fuller H B Co's trailing-twelve-month revenue grew 1.5% year on year, with a free-cash-flow margin of 2.8%. Where it lags: long-term debt as % of assets of 37.9% ranks 32 of 36 specialty chemicals companies we cover.

Our discounted-cash-flow model values the business at ~$43 per share in the base case (~$23–$69 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow fell 17.6% while net income grew 72.2%: a 90pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.

Things to watch

  • Weak cash conversion. Free cash flow was 51% of net income over the last 12 months.
  • Below peers: long-term debt as % of assets. Long-term debt as % of assets of 37.9% ranks 32 of 36 specialty chemicals companies we cover (median 26.8%).

Latest results: FY2026 Q3

Filed September 24, 2026
Earnings per share
$1.52 against an average estimate of $1.46: beat by 3.8%
Revenue
$938m, up 5.2% on a year earlier
Share reaction
-0.3% in the first session after the results on September 24, 2026, against +0.5% for the S&P 500
Guidance given
foreign exchange impact on net revenue growth growth 2% (fiscal 2026); adjusted EBITDA $655m to $670m (fiscal 2026)
Next report
January 13, 2027; average EPS estimate $1.36

Fuller H B's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+3.7%
  • 1 week+4.9%
  • 1 month+3.2%
  • This year-11.8%
  • 1 year-8.6%
  • 5 years-25.1%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$3.6B
Operating margin
9.5%
Net margin
5.6%
EPS (TTM, diluted)
$3.58

Growth

Revenue growth
+1.5%
Change in growth rate
+2.1 pts
Share count change
−0.9%

Cash

Free cash flow (TTM)
$100M
FCF margin
2.8%
Stock pay % of revenue
0.7%

Earnings

Last results
September 24, 2026
Next results (est.)
January 14, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Agreement
  2. Announcement
  3. Announcement
  4. Financing
  5. Announcement
  6. Dividend
  7. Leadership
  8. Results
  9. Guidance
  10. Results
  11. Announcement
  12. Announcement
  13. Results
  14. Announcement
  15. Deal
  16. Agreement

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Fuller H B Co valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: held for review: after-tax interest is 82% of the cash flow left for shareholders; our flat discount rate doesn't yet reflect debt this heavy.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Fuller H B Co as an operating company, with every model that fits that kind of business. Cost of equity 9%: the 10-year Treasury yield (4.9%) plus a beta of 0.9 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. — Does not apply: This model is withheld pending its input or assumption review.
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$76 ~$63–$89 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$42 ~$29–$61 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$42 ~$36–$51 Included
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Fuller H B Co with Specialty Chemicals in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$34.51$40.82$49.47$43.40$45.46$49.73$69.15$76.00$73.58$74.39$57.30$51.56
Market value$1.8bn$2.1bn$2.6bn$2.3bn$2.4bn$2.6bn$3.8bn$4.2bn$4.1bn$4.2bn$3.2bn$2.8bn
+ Net debt (− = net cash)$604m$561m$2.3bn$2.1bn$1.9bn$1.7bn−$62m−$80m$1.7bn$1.8bn$1.9bn$2.0bn
Enterprise value$2.4bn$2.7bn$4.8bn$4.4bn$4.2bn$4.3bn$3.7bn$4.1bn$5.8bn$6.1bn$5.1bn$4.8bn
Multiples
Price / sales 0.9x1.0x1.1x0.7x0.8x0.9x1.1x1.1x1.2x1.2x0.9x0.8x
Price / earnings 20.5x17.2x43.0x13.2x18.1x21.1x23.3x23.3x28.4x32.3x20.9x14.4x
Price / free cash flow 11.7x15.8x22.9x12.2x11.4x10.7x32.0x33.2x15.9x25.8x26.2x28.4x
EV / EBITDA 9.7x9.6x23.3x11.4x11.5x12.0x9.3x8.8x11.2x11.6x——

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

56 /100

Moderate moat

How hard Fuller H B's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 7 / 20

    Cash operating profit has been a median 6.2% of total assets over 10 years.

  • Pricing power 10 / 20

    Gross margin has been a median 27.5%, moving by 2.0 percentage points (standard deviation) across 10 years.

  • Durability 11 / 20

    Operating margin has been a median 8.2%; its worst year was 6.2%.

  • Cash conversion 12 / 20

    Free cash flow was positive in 9 of 10 years, at a median 5.6% of revenue.

  • Discipline 16 / 20

    The diluted share count rose 2.6% over five years; stock-based pay has been a median 0.7% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: January 13, 2027, after the close. Analysts expect revenue of $946m and EPS of $1.36 (range $1.31 to $1.42) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $4.85 +14% $3.6bn +4%
Next $5.15 +6% $3.9bn +7%

Next year's EPS estimate has moved −3.2% in 90 days, across 7 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −0.4% on 90 days ago. In the last 30 days, 3 analysts raised Fuller H B Co's forecast and 3 cut it.

Consensus EPS forecast Fuller H B Co, last 90 days
$4.80 $5.00 $5.20 $5.40 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $4.87 Current fiscal year, 60 days ago: $4.87 Current fiscal year, 30 days ago: $4.87 Current fiscal year, 7 days ago: $4.85 Current fiscal year, Now: $4.85 $4.85 Next fiscal year, 90 days ago: $5.32 Next fiscal year, 60 days ago: $5.32 Next fiscal year, 30 days ago: $5.25 Next fiscal year, 7 days ago: $5.18 Next fiscal year, Now: $5.15 $5.15

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $4.87$5.32
60 days ago $4.87$5.32
30 days ago $4.87$5.25
7 days ago $4.85$5.18
Now $4.85$5.15

Earnings against estimates

Quarter toEstimateActualSurprise
Aug 2026 $1.46 $1.52 +3.8%
May 2026 $1.38 $1.41 +2.5%
Feb 2026 $0.55 $0.57 +2.7%
Nov 2025 $1.21 $1.28 +5.7%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, September 24, 2026
  • Adjusted EPS (diluted) fiscal 2026 $4.70 to $4.85 Non-GAAP
    “Adjusted EPS (diluted) is now expected to be in the range of $4.70 to $4.85;” source
  • Foreign exchange impact on net revenue growth fiscal 2026 about 2% growth
    “Net revenue for fiscal 2026 is still expected to be up mid-single digits; organic revenue is still expected to be up low-single digits, with pricing up mid-single digits and volume down low-single digits; the impact from foreign exchange is now expected to be approximately 2%;” source
  • Adjusted EBITDA fiscal 2026 $655m to $670m Non-GAAP
    “Adjusted EBITDA for fiscal 2026 is now expected to be in the range of $655 million to $670 million;” source
  • Core tax rate, excluding the impact of discrete items fiscal 2026 25.5% to 26% Non-GAAP
    “Core tax rate, excluding the impact of discrete items, is now expected to be in the range of 25.5% to 26.0%;” source
  • Cash flow from operations, excluding the impact of AMS-related items fiscal 2026 $300m to $325m Non-GAAP Maintained
    “Cash flow from operations for fiscal 2026, excluding the impact of AMS-related items, is still expected to be in the range of $300 million to $325 million.” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Analyst recommendations

7 analysts, Nov 2026
Buy686%
Hold114%
Sell00%

Monthly trend

  1. Nov 20261517
  2. Oct 20261517
  3. Sep 20261517

Counts of recommendations published by analysts covering Fuller H B Co, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
6.0%
of tradable shares
Days to cover
2.34
at average volume
Short interest, 1 month
−19%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
0.3%
of shares
Employees
7,100
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −8.6%

$56.41 on October 31, 2025 to $51.56

ThenNowEffect
Revenue (last 12 months) $3.5bn $3.6bn +1.5%
Net margin 3.3% 5.6% +69.6%
P/E multiple 27.4x 14.4x −47.4%
Share count 56m 55m +0.9%

Biggest factor: p/e multiple.

Last 3 years −23.2%

$67.10 on November 3, 2023 to $51.56

ThenNowEffect
Revenue (last 12 months) $3.6bn $3.6bn −0.3%
Net margin 4.2% 5.6% +33.9%
P/E multiple 25.3x 14.4x −43.0%
Share count 56m 55m +1.1%

Biggest factor: p/e multiple.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
FUL+58%−11%+15%−16%−11%−12%
Industry peers (median)+17%−26%−9%+7%−15%+6%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
FUL75%50%42%42%42%46%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
FUL−14%−27%−15%−22%−28%−27%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 56% from August 24, 2018 to March 23, 2020. Getting back needed a 129% gain, reached on February 10, 2021, 324 days after the low.

Price behaviour

52-week range
$48.64 – $66.59
From 52-week high
−22.6%
vs 50-day average
+0.6%
vs 200-day average
−10.5%
Volatility (1 year)
34%
Beta vs S&P 500
0.87

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
4 up, 8 down
typical move ±3.5%
After a week
2 up, 10 down
typical move ±4.8%
After a month
5 up, 7 down
typical move ±6.6%
Results releasedNext dayS&P 500 next day5 days21 days
September 24, 2026 −0.3% +0.5% 0.0% −0.7%
June 25, 2026 −2.1% −0.6% −10.1% −12.5%
March 26, 2026 +4.3% −3.5% +6.7% +10.8%
January 15, 2026 −6.5% +0.2% −7.2% +3.8%
September 25, 2025 −1.9% +0.1% −0.3% +4.2%
June 26, 2025 +10.3% +1.3% +11.2% +4.6%
March 27, 2025 +0.8% −2.3% 0.0% −0.1%
January 16, 2025 −3.2% +0.8% −2.1% −6.0%
January 2, 2025 −7.0% +1.0% −9.2% −9.2%
September 26, 2024 −0.7% +0.3% −4.3% −7.0%
June 27, 2024 +0.9% −0.2% −0.9% +12.0%
March 28, 2024 −4.4% −0.2% −5.9% −8.5%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fuller H B Co in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Fuller H B Co
$3.5B $3.5B $3.6B $3.6B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $3.5B Revenue (TTM), FY24 Q1: $3.5B Revenue (TTM), FY24 Q2: $3.5B Revenue (TTM), FY24 Q3: $3.5B Revenue (TTM), FY24 Q4: $3.6B Revenue (TTM), FY25 Q1: $3.5B Revenue (TTM), FY25 Q2: $3.5B Revenue (TTM), FY25 Q3: $3.5B Revenue (TTM), FY25 Q4: $3.5B Revenue (TTM), FY26 Q1: $3.5B Revenue (TTM), FY26 Q2: $3.5B Revenue (TTM), FY26 Q3: $3.6B $3.6B

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $3.5B
FY24 Q1 $3.5B
FY24 Q2 $3.5B
FY24 Q3 $3.5B
FY24 Q4 $3.6B
FY25 Q1 $3.5B
FY25 Q2 $3.5B
FY25 Q3 $3.5B
FY25 Q4 $3.5B
FY26 Q1 $3.5B
FY26 Q2 $3.5B
FY26 Q3 $3.6B
Revenue growth, TTM YoY Fuller H B Co
-10% -5% 0% 5% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: -6.4% Revenue growth, TTM YoY, FY24 Q1: -5.1% Revenue growth, TTM YoY, FY24 Q2: -2.1% Revenue growth, TTM YoY, FY24 Q3: -0.5% Revenue growth, TTM YoY, FY24 Q4: 1.6% Revenue growth, TTM YoY, FY25 Q1: 1.0% Revenue growth, TTM YoY, FY25 Q2: -0.1% Revenue growth, TTM YoY, FY25 Q3: -1.3% Revenue growth, TTM YoY, FY25 Q4: -2.7% Revenue growth, TTM YoY, FY26 Q1: -2.6% Revenue growth, TTM YoY, FY26 Q2: -0.6% Revenue growth, TTM YoY, FY26 Q3: 1.5% 1.5%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 -6.4%
FY24 Q1 -5.1%
FY24 Q2 -2.1%
FY24 Q3 -0.5%
FY24 Q4 1.6%
FY25 Q1 1.0%
FY25 Q2 -0.1%
FY25 Q3 -1.3%
FY25 Q4 -2.7%
FY26 Q1 -2.6%
FY26 Q2 -0.6%
FY26 Q3 1.5%
Operating margin (TTM) Fuller H B Co
8% 9% 10% 11% FY22 Q4 FY23 Q3 FY24 Q2 FY25 Q3 Operating margin (TTM), FY22 Q4: 8.6% Operating margin (TTM), FY23 Q1: 8.8% Operating margin (TTM), FY23 Q2: 9.1% Operating margin (TTM), FY23 Q3: 9.3% Operating margin (TTM), FY23 Q4: 10.1% Operating margin (TTM), FY24 Q1: 10.3% Operating margin (TTM), FY24 Q2: 10.5% Operating margin (TTM), FY24 Q3: 10.9% Operating margin (TTM), FY24 Q4: 9.8% Operating margin (TTM), FY25 Q1: 9.2% Operating margin (TTM), FY25 Q2: 9.3% Operating margin (TTM), FY25 Q3: 9.5% 9.5%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Operating margin (TTM)
FY22 Q4 8.6%
FY23 Q1 8.8%
FY23 Q2 9.1%
FY23 Q3 9.3%
FY23 Q4 10.1%
FY24 Q1 10.3%
FY24 Q2 10.5%
FY24 Q3 10.9%
FY24 Q4 9.8%
FY25 Q1 9.2%
FY25 Q2 9.3%
FY25 Q3 9.5%
FCF margin (TTM) Fuller H B Co
0% 5% 10% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: 7.4% FCF margin (TTM), FY24 Q1: 8.7% FCF margin (TTM), FY24 Q2: 7.7% FCF margin (TTM), FY24 Q3: 7.2% FCF margin (TTM), FY24 Q4: 4.6% FCF margin (TTM), FY25 Q1: 2.1% FCF margin (TTM), FY25 Q2: 3.3% FCF margin (TTM), FY25 Q3: 3.5% FCF margin (TTM), FY25 Q4: 3.5% FCF margin (TTM), FY26 Q1: 4.2% FCF margin (TTM), FY26 Q2: 4.0% FCF margin (TTM), FY26 Q3: 2.8% 2.8%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 7.4%
FY24 Q1 8.7%
FY24 Q2 7.7%
FY24 Q3 7.2%
FY24 Q4 4.6%
FY25 Q1 2.1%
FY25 Q2 3.3%
FY25 Q3 3.5%
FY25 Q4 3.5%
FY26 Q1 4.2%
FY26 Q2 4.0%
FY26 Q3 2.8%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Nov 2009 2010 Nov 2010 2011 Dec 2011 2012 Dec 2012 2013 Nov 2013 2014 Nov 2014 2015 Nov 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Nov 2019 2020 Nov 2020 2021 Nov 2021 2022 Dec 2022 2023 Dec 2023 2024 Nov 2024 2025 Nov 2025 LTM Aug 2026
Income
Revenue 1,235 1,257 1,444 1,886 2,047 2,104 2,084 2,095 2,306 3,041 2,897 2,790 3,278 3,749 3,511 3,569 3,474 3,554
Gross profit 371 358 404 517 570 533 568 606 599 828 807 757 845 964 1,009 1,062 1,081 1,149
EBITDA 154 133 156 217 254 215 245 276 207 383 367 357 396 470 515 523 — —
Operating income 107 95 117 163 196 150 170 198 120 238 226 218 253 323 355 348 — —
Net income 84 71 89 126 97 50 87 122 59 171 131 124 161 180 145 130 152 198
Diluted EPS $1.70 $1.43 $1.79 $2.48 $1.89 $0.97 $1.69 $2.37 $1.15 $3.29 $2.52 $2.36 $2.97 $3.26 $2.59 $2.30 $2.75 $3.58
Growth (year on year)
Revenue −11.3% +1.8% +14.9% +30.6% +8.5% +2.8% −1.0% +0.5% +10.1% +31.9% −4.7% −3.7% +17.5% +14.4% −6.4% +1.6% −2.7% +1.5%
EBITDA +314.1% −13.3% +16.9% +39.1% +17.2% −15.3% +13.9% +12.4% −25.0% +85.2% −4.1% −2.7% +10.8% +18.7% +9.6% +1.5% — —
Operating income — −11.7% +23.6% +39.0% +20.3% −23.4% +13.8% +16.2% −39.7% +99.0% −5.0% −3.4% +15.7% +27.8% +10.0% −1.9% — —
Net income — −15.3% +25.7% +41.0% −23.0% −48.6% +74.2% +40.4% −51.2% +188.1% −23.6% −5.4% +30.5% +11.7% −19.6% −10.1% +16.7% +72.2%
Diluted EPS — −16.0% +25.3% +38.5% −23.8% −48.7% +74.2% +40.2% −51.5% +186.1% −23.4% −6.3% +25.8% +9.8% −20.6% −11.2% +19.6% +73.7%
Margins
Gross margin 30.1% 28.5% 28.0% 27.4% 27.9% 25.3% 27.3% 28.9% 26.0% 27.2% 27.9% 27.1% 25.8% 25.7% 28.7% 29.8% 31.1% 32.3%
EBITDA margin 12.5% 10.6% 10.8% 11.5% 12.4% 10.2% 11.8% 13.2% 9.0% 12.6% 12.7% 12.8% 12.1% 12.5% 14.7% 14.7% — —
Operating margin 8.7% 7.5% 8.1% 8.6% 9.6% 7.1% 8.2% 9.5% 5.2% 7.8% 7.8% 7.8% 7.7% 8.6% 10.1% 9.8% — —
Net margin 6.8% 5.6% 6.2% 6.7% 4.7% 2.4% 4.2% 5.8% 2.6% 5.6% 4.5% 4.4% 4.9% 4.8% 4.1% 3.6% 4.4% 5.6%
Free-cash-flow margin 3.9% 3.2% 3.8% 3.9% 0.4% −5.2% 7.3% 6.3% 4.8% 6.1% 7.2% 8.8% 3.6% 3.4% 7.4% 4.6% 3.5% 2.8%
Cash flow
Cash from operations 71 72 88 109 133 30 211 196 166 253 269 332 213 257 378 302 263 289
Capital spending 23 32 33 36 124 140 59 63 55 68 62 87 96 130 119 139 142 189
Free cash flow 49 40 55 73 8 −110 152 132 111 185 207 244 117 127 259 163 121 100
Stock-based pay 6 6 8 10 12 13 14 13 18 17 24 17 22 24 20 22 22 24
Free cash flow after stock pay 43 34 48 63 −4 −123 138 119 94 168 183 227 95 102 239 141 99 76
Balance sheet
Cash 99 155 155 200 155 78 119 142 194 151 112 101 62 80 179 169 107 97
Total debt 163 223 232 520 493 575 723 703 2,452 2,248 1,979 1,774 — — 1,838 2,011 2,017 2,055
Net debt (negative = net cash) 64 69 78 320 338 497 604 561 2,258 2,097 1,867 1,673 −62 −80 1,659 1,841 1,910 1,957
Diluted shares 49m 50m 50m 51m 51m 51m 51m 51m 52m 52m 52m 53m 54m 55m 56m 57m 55m 55m
Returned to shareholders
Dividends 13 14 15 16 19 23 26 28 30 31 32 33 35 39 43 48 50 52
Buybacks 0 0 9 4 18 16 19 23 22 5 3 3 3 4 3 40 61 49
Total returned 13 14 23 21 37 39 45 51 51 36 35 37 38 43 46 87 111 101

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 6 checks passed · August 29, 2026
What it owns · $5.4bn
Short-term assets $1.5bnLonger-term assets $3.9bn
What it owes, and who funded it · $5.4bn
Short-term liabilities $818mLonger-term liabilities $2.4bnShareholders' equity $2.2bn
  • Short-term assets cover short-term liabilities $1.5bn of assets due within a year against $818m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $1.5bn short-term assets against $2.4bn of longer-dated liabilities.
  • More cash than debt $97m of cash against $2.1bn of debt.
  • Debt below 40% of shareholders' equity Debt is 95% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 115% to 95% over five years.
  • A year's operating cash flow covers at least 20% of debt $289m of operating cash flow against $2.1bn of debt.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Fuller H B Co's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2026 Q3 TTM
Buybacks (TTM)
$48.8M
Dividends (TTM)
$51.9M
Returned to shareholders
101%
of free cash flow
Buybacks, last 3 fiscal years
$103M
Diluted share count
−0.9%
year over year
Total shareholder yield
3.6%
dividends 1.9% + buybacks 1.8% of market value
Dividend payout ratio
26%
of net income paid out
Sales & admin spending
21.6%
of revenue
Days sales outstanding
67 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in specialty chemicals
Last 12 months unless stated FUL ESI CBT AVNT NEU AXTA Median
Revenue, last 12 months $3.6bn $3.5bn $3.6bn $3.3bn $2.8bn $5.2bn $906m
Revenue growth, last 12 months 1.5% 39.6% −4.7% 2.4% 0.9% 0.1% 5.4%
Revenue growth, 3-year average −0.1% 14.4% −3.8% 0.5% 0.4% 0.3% 0.9%
Revenue growth, latest quarter 5.2% 51.7% 6.4% 5.8% 3.8% 1.8% 8.3%
Gross margin 32.3% 36.6% 22.7% 31.7% 31.7% 33.6% 28.8%
Operating margin 9.5% 11.7% 13.6% 9.5% 20.2% 12.4% 4.3%
Operating margin, 3-year average 9.9% 13.0% 15.2% 8.4% 20.3% 13.3% 5.5%
Net margin 5.6% 5.9% 5.2% 5.1% 16.5% 6.5% 0.8%
Cash from operations / revenue 8.1% 8.1% 13.7% 9.0% 18.1% 13.5% 6.9%
Free-cash-flow margin 2.8% 5.2% 7.7% 5.7% 13.8% 9.6% 4.3%
Free-cash-flow margin, 3-year average 4.5% 9.1% 9.0% 5.1% 16.4% 8.7% 5.1%
Stock pay / revenue 0.7% 2.2% 0.5% 0.3% 0.1% 0.6% 1.0%
Change in share count −0.9% 0.4% −3.7% 0.2% −1.9% −1.6% 0.1%

Median of all 42 companies we cover in specialty chemicals. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

42 specialty chemicals companies
Measure Company Peer median Rank
Revenue growth Growth 1.5% 6.0% 27 of 42
Change in growth rate Growth +2.1pp +1.3pp 18 of 42
Gross margin Profitability 32.3% 31.5% 16 of 40
Operating margin Profitability 9.5% 3.8% 10 of 39
Net margin Profitability 5.6% 1.7% 13 of 42
Free-cash-flow margin Cash generation 2.8% 4.8% 23 of 42
Stock pay as % of revenue Cash generation 0.7% 1.0% 13 of 36
Long-term debt as % of assets Balance sheet 37.9% 26.8% 32 of 36
Change in share count Balance sheet -0.9% 0.0% 13 of 37
Days sales outstanding Balance sheet 67 days 59 days 19 of 30

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to November 29, 2025
Geography
Region Revenue YoY
Countries With More Than10 Percent of Total $2.3B ▼ 4.3%
Americas $1.8B ▼ 6.7%
United States $1.5B ▼ 6.3%
All Other Countries With Less Than10 Percent of Total $1.2B ▲ 0.8%
EIMEA $1B ▲ 2.0%
Asia Pacific $645M ▲ 2.1%
China $447M ▲ 2.0%
Germany $352M ▼ 2.9%

These categories overlap or exclude eliminations, so shares aren't shown.

From Fuller H B Co's 10-K filed January 22, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$3.3B
Institutions reporting
347
Shares held vs prior quarter
▼ 0.5%
Positions opened / closed
54 / 43

Top buyers and sellers, Q2 2026: 174 institutions bought and 149 sold ; the biggest buyer was Ancora Advisors LLC (+1.3M shares) and the biggest seller Capital World Investors (−2.4M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $484M 8.3M 14.8% ▲ 3.5%
Vanguard Portfolio Management LLC $224M 3.8M 6.9% ▲ 2.7%
State Street Corp $167M 2.9M 5.1% ▲ 3.7%
Dimensional Fund Advisors LP $167M 2.9M 5.1% ▲ 9.6%
Vanguard Capital Management LLC $143M 2.5M 4.4% ▲ 1.0%
Mairs & Power Inc $142M 2.4M 4.3% ▲ 3.1%
Neuberger Berman Group LLC $139M 2.4M 4.3% ▲ 70.7%
Kayne Anderson Rudnick Investment Management LLC $117M 2.0M 3.6% ▼ 3.7%
Geode Capital Management, LLC $84.9M 1.5M 2.6% ▲ 6.2%
Ancora Advisors LLC $73.3M 1.3M 2.2% New
Cooke & Bieler LP $64.4M 1.1M 2.0% ▼ 29.3%
FMR LLC $63.3M 1.1M 1.9% ▼ 6.5%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Fuller H B Co's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $1.5M 13 trades by 10 insiders, last 12 months Insider sales History → $1M 2 trades by 1 insider · 0% under pre-set plans
Net ▲ $500,862 net buying
Insider Date Trade Shares Price Value
Malik Muhammad Shahbaz Senior VP, BAS October 16, 2026 Buy 479 $52.23 $25,000
Bailly R Jeffrey Director October 7, 2026 Buy 10,000 $50.00 $500,000
Martin Celine Christine Director September 30, 2026 Buy 465 $49.50 $22,998
Happe Michael J Director September 29, 2026 Buy 2,000 $49.63 $99,250
Zaheer Srilata Director September 29, 2026 Buy 40 $49.97 $1,999
Lauber Charles T Director September 29, 2026 Buy 2,005 $49.87 $99,989
Zaheer Srilata Director September 28, 2026 Buy 2,000 $49.06 $98,120
Rasmussen Trangsrud Teresa J Director September 28, 2026 Buy 500 $48.98 $24,490
Rasmussen Trangsrud Teresa J Director September 28, 2026 Buy 1,542 $48.96 $75,496
Handley Thomas W Director September 28, 2026 Buy 2,000 $49.41 $98,820
Florness Daniel L Director September 28, 2026 Buy 2,030 $49.34 $100,160
Weaver Nathan D. Exec VP, Business Transform. August 11, 2026 Sell 9,561 $62.06 $593,356

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 1 trade and filings

No trades in Fuller H B Co disclosed in the last 12 months; 1 earlier trade on record.

  • Van Taylor(R-TX 3):Sale (full), $1,001 - $15,000, traded March 25, 2019, filed April 15, 2019

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around January 14, 2027 estimated from the company's past filing pattern, not announced

  • September 24, 2026
  • June 25, 2026
  • March 26, 2026
  • January 15, 2026
  • September 25, 2025
  • June 26, 2025

Recent SEC filings

Data status

When each part of this page on Fuller H B Co was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Fuller H B Co in brief

What does Fuller H B Co do?
Fuller H B Co is a US-listed company in the specialty chemicals industry. Its financial year ends in November.
What is Fuller H B Co's stock ticker?
Fuller H B Co trades under the ticker FUL on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Fuller H B Co's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Fuller H B Co reported revenue of $3.6B, 1.5% higher than a year earlier, according to its SEC filings.
What is Fuller H B Co's free cash flow?
Fuller H B Co's free-cash-flow margin is 2.8% of revenue over the trailing twelve months, ranking 23 of the 42 specialty chemicals companies we cover.
Who are Fuller H B Co's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Portfolio Management LLC and State Street Corp. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Fuller H B Co buying back stock, and does it pay a dividend?
Fuller H B Co spent $48.8M on share repurchases over the trailing twelve months, and its diluted share count fell 0.9% over the year.
What is Fuller H B Co's market cap?
On November 2, 2026, Fuller H B Co's market capitalisation was about $2.8B, with a price-to-earnings ratio of 14.4 and net debt of $2B. Market figures come from third-party market data and may be delayed.
Does Fuller H B Co pay a dividend?
Yes: Fuller H B Co paid $51.9M in dividends over the trailing twelve months, a dividend yield of 1.87% and a payout ratio of 26.2%.
How much debt does Fuller H B Co have?
Fuller H B Co's debt-to-equity ratio is 94.8%, from its latest balance sheet (114.8% five years earlier). The financial health section below sets out its other solvency checks.
Who are Fuller H B Co's competitors?
In our Specialty Chemicals peer group, the companies closest to Fuller H B Co are Element Solutions Inc, Cabot Corp, Avient Corp, Newmarket Corp and Axalta Coating Systems Ltd. The side-by-side comparison below sets their revenue, margins and growth against Fuller H B Co's.
Are insiders buying or selling Fuller H B Co stock?
Over the last 12 months, Fuller H B Co's directors and officers reported 13 open-market purchases and 2 sales on Form 4. The insider trading page charts every trade.
When is Fuller H B Co's next earnings date?
Around January 13, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Fuller H B Co announces its own schedule.